¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 ÀϹݿ¬Á¦ ¹ßÇ¥ ¾È³»

  1. ¹ßÇ¥½Ã°£ ¹× ¹ßÇ¥Àå¼Ò : Çмú´ëȸ ȨÆäÀÌÁö ¡®¹ßÇ¥ÀÚ ¾È³»¡¯¿¡¼­ È®ÀÎ
  2. ¹ßÇ¥½½¶óÀ̵å Á¦Ãâ : 2016³â 9¿ù 19ÀÏ(¿ù)±îÁö office@ksog.org·Î Á¦Ãâ(PPTÆÄÀÏ)
    ¹ßÇ¥½½¶óÀ̵å´Â »çÀü¿¡ ¹Ýµå½Ã Á¦ÃâÇÏ¿©¾ß Çϸç, ¹ßÇ¥ ´çÀÏ ¼öÁ¤µÈ ÆÄÀÏ·Î ±³Ã¼°¡´ÉÇÔ
    (¹ßÇ¥½½¶óÀÌµå ¹ÌÁ¦Ãâ½Ã ¹ßÇ¥Æ÷±â·Î °£ÁÖÇÔ)
  3. ¹ßÇ¥°ü·Ã À¯ÀÇ»çÇ×
    - ½½¶óÀ̵å´Â 15¸Å À̳», 1Àå´ç 10ÁÙ À̳»·Î Á¦ÀÛÀ» ±ÇÀåÇÔ
    - ÁöÁ¤µÈ ¹ßÇ¥½Ã°£(7ºÐ ¹ßÇ¥, 3ºÐ ÁúÀÇÀÀ´ä ÃÑ 10ºÐ)À» ÁؼöÇÏ¿©¾ß ÇÔ
    - ¹ßÇ¥´çÀÏ 4Ãþ Preview Room¿¡¼­ ÃÖÁ¾ ¹ßÇ¥ÆÄÀÏÀ» È®ÀÎÇϰųª ¼öÁ¤ÆÄÀÏÀ» Á¦Ãâ°¡´É
    (»çÀü Á¦ÃâÀÚ·á¿¡¼­ º¯°æÀÌ ¾ø´õ¶óµµ È®ÀÎÇÏ¿©¾ß Çϸç, ƯÈ÷ µ¿¿µ»óÀ» »ç¿ëÇÏ´Â °æ¿ì¿¡´Â È®ÀÎÇʼö)
¸ðüžÆÀÇÇР/   ºÎÀÎÁ¾¾çÇР /   »ý½Ä³»ºÐºñÇР /   ÀϹݺÎÀΰúÇÐ
ÀϹݿ¬Á¦ : »ý½Ä³»ºÐºñÇÐ - ÀϽà : 2016³â 9¿ù 23ÀÏ (±Ý)
- Àå¼Ò : ÄÁº¥¼ÇȦ B[4F]
RE01-RE05 (08:20~09:10) ÁÂÀå : ³ª¿ëÁø(ºÎ»êÀÇ´ë)
RE0108:20~08:30 ¼Õ±Ý¼±
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
DNA double strand break repair Àå¾Ö°¡ Àڱ󻸷Áõ ¹ßº´¿¡ ¹ÌÄ¡´Â ¿ªÇÒ
RE0208:30~08:40 Á¤À¯¿¬
°¡Å縯ÀÇ´ë ´ëÀü¼º¸ðº´¿ø »êºÎÀΰú
Interleukin-17A and Th17 cells contribute to endometrial cell survival in endometriosis
RE0308:40~08:50 ±èÁ¤¼÷
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Aberrant expressions of transmembrane chloride ion channels in endometriosis
RE0408:50~09:00 ±è¹Î°æ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
High mobility group box-1 and inflammatory cytokines in follicular fluid of patient with Endometriosis
RE0509:00~09:10 ³ë¾Æ¹Ì
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
³­¼ÒÀÇ Àڱ󻸷Á¾ ¼ö¼ú ÈÄ µð¿¡³ë°Ô½ºÆ®¸¦ Àå±â°£ Åõ¿©ÇÑ ÀÓ»ó °æÇè
RE06-RE10 (09:10~10:00) ÁÂÀå : ±è¼®Çö(¼­¿ïÀÇ´ë)
RE0609:10~09:20 ¹ÚÁÖÇö
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Erythroblast cell differentiation of human endometrium derived induced pluripotent stem cells as a source of autologous transfusion
RE0709:20~09:30 À±ÁÖÈñ
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú
Preliminary report of anatomical success in porcine uterus transplantation without deep uterine vessels re-anastomosis
RE0809:30~09:40 ±è³ª¿µ
ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø »êºÎÀΰú
Relationship between serum estrone to estradiol ratio and insulin resistance-related parameters in women with polycystic ovary syndrome
RE0909:40~09:50 ÃÖÁ¤ÀÎ
°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø »êºÎÀΰú
ȯ°æÈ£¸£¸óÀÌ Æó°æ ÈÄ ÁãÀÇ °ñ¹Ðµµ ¹× °ñ´ë»ç¹°Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ
RE1009:50~10:00 ÀÌÁÖÇÐ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
Çѱ¹ À¯¹æ¾Ï ȯÀÚ¿¡¼­ Tamoxifen°ú Aromatase inhibitor¿¡ ÀÇÇÑ Àڱ󻸷ÁúȯÀÇ À§Ç輺
ÀϹݿ¬Á¦ : »ý½Ä³»ºÐºñÇÐ - ÀϽà : 2016³â 9¿ù 23ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F]
RE11-RE15 (15:30~16:20) ÁÂÀå : ¾çȸ»ý(µ¿±¹ÀÇ´ë)
RE1115:30~15:40 ¿°Çö½Ä
ÀÌ·ë¿©¼ºÀÇ¿ø
Ectopic pregnancy rates in blastocyst stage versus cleavage stage embryo transfer: A systematic review and meta-analysis for rare events data
RE1215:40~15:50 À°Áø¼º
À»ÁöÀÇ´ë À»Áöº´¿ø »êºÎÀΰú
Comparison of single-dose and non-single-dose protocol of methotrexate in treatment of ectopic pregnancy: a systematic review and meta-analysis
RE1315:50~16:00 ÀüÁöÇö
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
³»ºÐºñ ±³¶õ ¹°Áú (ºñ½ºÆä³î A, ÇÁÅ»·¹ÀÌÆ®)ÀÌ ºÎÀΰú Áúȯ¿¡ ¹ÌÄ¡´Â ¿µÇâ
RE1416:00~16:10 Ȳȿ¼ø
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Waist circumference and Mortality in Korean elderly women
RE1516:10~16:20 ¿°Çö½Ä
ÀÌ·ë¿©¼ºÀÇ¿ø
To pill or not to pill in GnRH antagonist cycles: A systematic review and bayesian meta-analysis of randomized controlled trials